Mattia Galli/LinkedIn
Oct 5, 2025, 08:21
Mattia Galli Gives a Talk on Pharma Pulse About “De-escalation” of Antiplatelet Therapy in ACS
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared on LinkedIn:
”How far can we go with the “de-escalation” of antiplatelet therapy in patients with acute coronary syndrome?
We talk about it in our Pharma Pulse following the publication of the NEO-MINDSET trial.”
Read the full article in EHJ.
Article: Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome
Authors: Mattia Galli, Felice Gragnano, Marco Valgimigli
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera